tiprankstipranks
Carmell Therapeutics (CTCX)
NASDAQ:CTCX
US Market
Holding CTCX?
Track your performance easily

Carmell Therapeutics (CTCX) Financial Statements

34 Followers

Carmell Therapeutics Financial Overview

Carmell Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.56; its P/E ratio is -0.44; Carmell Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 20.52K$ 12.32K-$ 3.73M-
Gross Profit$ 15.68K$ 12.03K-$ 2.18M-
EBIT$ -2.87M$ -3.30M$ -468.93K$ -11.07M$ -5.04M
EBITDA$ -2.83M$ -3.24M$ -397.89K$ -10.64M$ -4.97M
Net Income Common Stockholders$ -2.88M$ -3.30M$ -3.27M$ -11.51M$ -5.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.14M$ 2.20M$ 892.16K$ 7.97M$ 10.24K
Total Assets$ 2.44M$ 5.03M$ 6.18M$ 82.22M$ 160.30M
Total Debt$ 781.70K$ 798.74K$ 1.54M$ 882.01K$ 0.00
Net Debt$ -355.62K$ -1.40M$ 652.18K$ -7.09M$ -10.24K
Total Liabilities$ 6.51M$ 6.41M$ 7.57M$ 61.31M$ 4.11M
Stockholders Equity$ -4.06M$ -1.37M$ -1.39M$ 20.92M$ -2.40M
Cash Flow-
Free Cash Flow$ -1.40M$ -1.14M$ -1.08M$ -5.06M$ -510.65K
Operating Cash Flow$ -1.40M$ -1.14M$ -1.08M$ -5.03M$ -480.18K
Investing Cash Flow--$ -748.80K$ 632.53K$ -30.47K
Financing Cash Flow$ 341.68K$ 2.44M$ -195.73K$ 12.41M$ 499.38K
Currency in USD

Carmell Therapeutics Earnings and Revenue History

Carmell Therapeutics Debt to Assets

Carmell Therapeutics Cash Flow

Carmell Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis